-
Document de presse | 2023.09.19
Development of an onco-therapeutic vaccine candidate against human papillomavirus (HPV)-induced cancers, based on preclinical results showing 100% efficacy
The Biotech TheraVectys, in collaboration with Institut Pasteur-TheraVectys Joint Laboratory, has just demonstrated the preclinical efficacy of its "Lenti-HPV-07" lentiviral vector-based vaccine candidate, administered intramuscularly, against cervical and oropharyngeal cancers induced by human papillomavirus (HPV). These results were published in EMBO Molecular Medicine journal on September 7,...
-
News | 2023.09.11
Food safety and antibiotic resistance: the fight against Listeria and Salmonella
The Fondation Le Roch-Les Mousquetaires is supporting two research projects at the Institut Pasteur on food safety and combating antibiotic resistance.
-
Document de presse | 2023.09.28
Malaria: treatment of Plasmodium falciparum malaria patients under threat in the Horn of Africa
Diagnosis of Plasmodium falciparum malaria using rapid diagnostic tests and treatment with artemisinin derivatives, the main component of the malaria treatments recommended by the World Health Organization (WHO), are under threat in the Horn of Africa. Scientists from the Laboratory of Parasitology and Medical Mycology at the University of Strasbourg and Strasbourg University Hospital, in...
-
Fiche maladie | 2015.10.06
Botulism
Botulism is a severe neurological disease caused by a highly potent toxin produced by Clostridium botulinum bacteria. There are different types of botulism: foodborne botulism, infant botulism and wound botulism. Although botulism is rare, the mortality rate is high if treatment is not administered immediately.
-
Portrait | 2023.10.02
Javier Pizarro-Cerda : science, plague and rock'n roll!
Javier Pizarro-Cerda's upbringing gave him curiosity, an interest in biology and science, as well as a lifelong passion for music! After his studies in Costa Rica, he came to Europe to become a scientist.Today at the Institut Pasteur in Paris, his research on plague and other Yersinia infections follows on from the work of his predecessors and also explores the history of deadly epidemics of the...
-
News | 2023.10.02
Malaria: progress towards the use of monoclonal antibodies
Although monoclonal antibodies seem to be a promising avenue for malaria prevention, their mechanism of action remains unclear. Scientists at the Institut Pasteur recently developed a model to study and identify more effective monoclonal antibodies.
-
Document de presse | 2023.10.03
The Institut Pasteur & the University of Tokyo have signed a LOI to establish the Planetary Health Innovation Center, marking the first step towards the Institut Pasteur of Japan
At a ceremony in Tokyo on Tuesday October 3, 2023 attended by the French Ambassador to Japan, H.E. Philippe Setton, the President of the Institut Pasteur, Professor Stewart Cole, and the President and Rector of the University of Tokyo, Professor Teruo Fujii, signed a letter of intent (LOI) to establish the Planetary Health Innovation Center (PHIC), marking the first step towards the Institut...
-
News | 2023.09.29
Foodborne botulism: report on the recent outbreak
In early September 2023, several people were infected after eating home-canned sardines in a bar in Bordeaux. By September 14, 2023, the outbreak had led to the death of one person, and 10 others had been admitted to hospital. Here is a detailed timeline of events and the Institut Pasteur's role in managing this health crisis.
-
News | 2023.10.06
Diphtheria: a novel bacterial species identified
A team from the Institut Pasteur has described a novel bacterial species in the Corynebacteriaceae family, capable of causing diphtheria. The identification of this distinct species will pave the way for improved surveillance and disease prevention.
-
Document de presse | 2023.10.25
New discovery concerning receptors used by coronaviruses to enter human cells
The SARS-CoV-2 virus responsible for COVID-19 can cause severe acute respiratory syndrome, contrasting with other coronaviruses that were known to cause mild seasonal colds prior to its emergence in 2019. This raises the question of why one coronavirus affects humans more severely than another. Scientists at the Institut Pasteur, Université Paris Cité and the VRI have now provided part of the...
